Jefferies Group's FOLD Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 40,300 shares of Amicus Therapeutics, Inc. (FOLD) worth $582,738, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in FOLD, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 187,897 shares. Largest reduction occurred in Q1 2026, reducing 125,185 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Amicus Therapeutics (FOLD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amicus Therapeutics (FOLD) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -125,185 | Reduce 75.65% | 40,300 | $14.46 |
| Q3 2025 | -58,315 | Reduce 26.06% | 165,485 | $7.88 |
| Q2 2025 | +35,903 | Add 19.11% | 223,800 | $5.73 |
| Q1 2025 | +187,897 | New Buy | 187,897 | $8.16 |
| Q1 2024 | -29,494 | Sold Out | 0 | $0.00 |
| Q4 2023 | -24,279 | Reduce 45.15% | 29,494 | $14.19 |
| Q3 2023 | -38,512 | Reduce 41.73% | 53,773 | $12.16 |
| Q2 2023 | +92,285 | New Buy | 92,285 | $12.56 |
Jefferies Group's Amicus Therapeutics Investment FAQs
Jefferies Group first purchased Amicus Therapeutics, Inc. (FOLD) in Q2 2023, acquiring 92,285 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Amicus Therapeutics, Inc. (FOLD) for 9 quarters since Q2 2023.
Jefferies Group's largest addition to Amicus Therapeutics, Inc. (FOLD) was in Q1 2025, adding 187,897 shares worth $1.53 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 40,300 shares of Amicus Therapeutics, Inc. (FOLD), valued at approximately $582,738.
As of the Q1 2026 filing, Amicus Therapeutics, Inc. (FOLD) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Amicus Therapeutics, Inc. (FOLD) was 223,800 shares, as reported at the end of Q2 2025.